- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04130867
Rehabilitation Manometry Study
Defining Novel Pharyngeal Pressure Metrics to Predict Dysphagia Treatment Outcomes and Clinical Prognosis Using High-resolution Manometry
Oropharyngeal dysphagia, or difficulty swallowing, is a devastating condition that affects physiological and psychosocial functioning in 1 in 25 adults. Many dysphagia treatments exist, but our ability to adequately measure treatment outcomes is limited. Pharyngeal high-resolution manometry (pHRM) directly measures swallowing pressures, providing an objective measurement of physiology that characterizes the basic mechanisms of swallowing. pHRM is well-poised to measure outcomes of dysphagia treatments due to its direct, objective, and reproducible measures of swallowing function.
This proposed project will address a central hypotheses that objective swallowing measures (including (pHRM) will reveal treatment-mediated swallowing changes, will align with patient-reported outcome measures, and will be able to predict who will benefit from treatment. The investigators will follow a cohort of participants with oropharyngeal dysphagia as they undergo either pharyngeal strengthening therapy or relief of upper esophageal sphincter outlet obstruction at three time points: baseline, mid-treatment (4-6 weeks) and post-treatment (10-12 weeks). The investigators will compare participants to healthy controls using pHRM, videofluoroscopy, diet assessment, functional reserve tests, and patient-reported outcome measures.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Suzan Abdelhalim, MD, MPH
- Phone Number: 608-265-2470
- Email: abdelhalim@surgery.wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- Recruiting
- University of Wisconsin
-
Contact:
- Suzan Abdelhalim, MD, MPH
- Phone Number: 608-265-2470
- Email: abdelhalim@surgery.wisc.edu
-
Principal Investigator:
- Timothy McCulloch, MD, FACS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
300 adults will be recruited to participate in the study. Participants will include 250 patients with heterogeneous causes of dysphagia undergoing active swallowing treatment and 50 age- and sex-match control participants with healthy swallow function. Participants will be stratified into the following goals of swallowing rehabilitation: Group A) Pharyngeal strengthening (n=125); and Group B) Relief of upper esophageal sphincter (UES) dysfunction or pharyngeal outlet obstruction (n=125). Classification will be based on clinician-driven diagnoses and treatment goals based on standard of care evaluation. The control group of healthy individuals will be Group C (n=50).
Participants' age may range from 18-99 years old; as dysphagia is more frequent in the elderly, the sample will most likely include individuals age 60 and over.
Description
Inclusion Criteria:
Pathological Group
Must have dysphagia as diagnosed by a licensed and certified otolaryngologist, gastroenterologist, or speech-language pathologist AND must have a dysphagia treatment plan that includes one of the following primary goals:
- Therapy to strengthen oropharyngeal musculature
- Medical or surgical management to relieve an obstruction at the upper esophageal sphincter
- Must agree to comply with swallowing assessment, including interview and manometry
- Must sign the Informed Consent form approved by the Health Sciences Institutional Review Board of the University of Wisconsin
Normal Group
- Having no swallowing disorders
- Must agree to comply with swallowing assessment, including interview and manometry
- Must sign the Informed Consent form approved by the Health Sciences Institutional Review Board of the University of Wisconsin.\
Exclusion Criteria:
Pathological Group
- Therapeutic management plan already initiated prior to recruitment
- Therapy goals including only improvement of swallowing coordination
- Developmental disability, dementia, cognitive dysfunction, or difficulty comprehending instructions
- Positive history of allergic response to topical anesthetic
- Allergy to food relevant to study participation (e.g. lactose intolerance)
Normal Group
- Known swallowing disorder
- Developmental disability, dementia, cognitive dysfunction, or difficulty comprehending instructions
- Positive history of allergic response to topical anesthetic
- Allergy to food relevant to study participation (e.g. lactose intolerance)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group A: Swallow Therapy Oropharyngeal Strengthening
Participants receiving any standard of care swallow therapy with oropharyngeal strengthening as the primary goal Participants will undergo pHRM, videofluoroscopy (VF), diet assessment, functional reserve tests, and patient--reported outcome questionnaires at 3 standardized time points: baseline, 4 to 6 weeks (mid therapy), and 10 to -12 weeks (post -therapy) |
Pharyngeal high--resolution manometry (pHRM) provides direct and objective measurement of pressure changes in the pharynx that characterize basic mechanisms of swallowing.
Videofluoroscopic Swallow Study (VFSS) enables real-time visualization of bolus flow during swallow movement.
|
Group B: Surgical Treatment Esophageal Sphincter
Participants receiving surgical treatment for relief of upper esophageal sphincter outlet obstruction. Participants will undergo pHRM, videofluoroscopy (VF), diet assessment, functional reserve tests, and patient--reported outcome questionnaires at 3 standardized time points: baseline, 4 to 6 weeks (mid therapy), and 10 to -12 weeks (post therapy) |
Pharyngeal high--resolution manometry (pHRM) provides direct and objective measurement of pressure changes in the pharynx that characterize basic mechanisms of swallowing.
Videofluoroscopic Swallow Study (VFSS) enables real-time visualization of bolus flow during swallow movement.
|
Group C: Healthy Controls
Healthy controls (n=50) will also undergo data collection at parallel time points, without completion of a treatment paradigm.
|
Pharyngeal high--resolution manometry (pHRM) provides direct and objective measurement of pressure changes in the pharynx that characterize basic mechanisms of swallowing.
Videofluoroscopic Swallow Study (VFSS) enables real-time visualization of bolus flow during swallow movement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pHRM from Baseline
Time Frame: up to 3 months
|
pHRM data collected from the 250 adults undergoing dysphagia treatment and 50 healthy controls at three time points (baseline, mid-treatment, and post-treatment) will be used.
|
up to 3 months
|
Change in Sydney Swallowing Questionnaire between timepoints
Time Frame: baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
The Sydney Swallowing Questionnaire is a 17-item inventory scored on a visual analog scale (VAS) (with the exception of Q12) developed to measure symptomatic severity of pharyngeal dysphagia.
Each VAS is 100 mm, where the left side of the scale is lesser symptoms and the right hand of the scale is increased symptoms.
Scoring is measured in distance (mm) from the left.
Maximum range in the scoring is 0 - 1700, the higher the score, the more severe the symptoms.
|
baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Change in Eat Assessment Tool Score between timepoints
Time Frame: baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
The Eat Assessment Tool is a 10-item survey where each item is scored 0-4 where 0 is no problem and 4 is severe problem.
The total range in score is 0-40 where higher scores indicate increased severity of symptoms.
|
baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Change in Hand Grip Strength Test between timepoints
Time Frame: baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Participants will squeeze a dynamometer at maximum pressure 3 times and hold for 5 seconds each.
10 seconds rest will be given between each trial.
|
baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Change in Maximum Isometric Pressure between timepoints
Time Frame: baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
The Iowa Oral Pressure Instrument (IOPI) will be used to measure maximum isometric pressure.
IOPI will be used to evaluate anterior and posterior maximal isometric tongue-pressures.
A small (3.5 cm long and 4.5 cm in diameter) air-filled plastic pressure bulb will be placed in the mouth at two different positions: directly posterior to the incisors and at the posterior oral tongue.
Participants will be asked to squeeze the bulb against the roof of the mouth with maximal effort and to perform saliva swallows.
Three tasks in each position will be recorded and participants will rest for 10 seconds between each trial.
|
baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Change in Dietary Assessment between timepoints
Time Frame: baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Participants will undergo diet assessment by using International Dysphagia Diet Standardisation Initiative Framework.
This framework defines and scores food textures/consistencies for participants with dysphagia.
Liquids are scored 0-4 where 0 is thin and 4 is extremely thick.
Foods are scored from 3-7 where 3 is liquidized food and 7 is regular food.
|
baseline, mid-treatment 4-6 weeks, post-treatment 10-12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Timothy McCulloch, MD, FACS, University of Wisconsin, Madison
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-0576
- A539770 (Other Identifier: UW, Madison)
- SMPH/SURGERY/SURGERY*OT (Other Identifier: UW Madison)
- Protocol Ver 0.06, 1/16/2021 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oropharyngeal Dysphagia
-
Peter Belafsky, MDTerminatedDysphagia | Oropharyngeal Dysphagia (OPD)United States
-
Morinaga Milk Industry Co., LTDHospital de MataróRecruitingDysphagia | Swallowing Disorder | Dysphagia, Oral Phase | Dysphagia, Esophageal | Dysphagia, OropharyngealSpain
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CambridgeCompletedDysphagia, OropharyngealUnited Kingdom
-
Complexo Hospitalario Universitario de A CoruñaCompleted
-
Hvidovre University HospitalRecruitingDeglutition Disorders | Dysphagia, OropharyngealDenmark
-
Peter Belafsky, MDCook MyoSiteRecruitingOropharyngeal DysphagiaUnited States
-
Region Örebro CountyUnknownDysphagia | Oropharyngeal Dysphagia
-
University of California, DavisCalifornia Institute for Regenerative Medicine (CIRM); Cook MyoSiteRecruitingOropharyngeal DysphagiaUnited States
-
All India Institute of Medical Sciences, New DelhiRecruitingOropharyngeal Dysphagia | Dysphagia, Late Effect of Stroke | Transfer Dysphagia | Cricopharyngeus Muscle DysfunctionIndia
-
Hospital de MataróCompletedDysphagia | Oropharyngeal Dysphagia | Swallowing DisorderSpain
Clinical Trials on pHRM
-
University of FloridaCompleted